We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmaker’s Web Page Omits Risk Info, Resulting in Untitled Letter
Drugmaker’s Web Page Omits Risk Info, Resulting in Untitled Letter
The FDA chided Citius Pharmaceuticals for a webpage promoting its product Suprenza that omits risk information and makes overblown claims about the weight loss drug.